incontinence: evaluation and management
DESCRIPTION
Incontinence: Evaluation and Management. Bernard D. Morris, Jr, MD, FACS Killeen Hemingway Clinics Scott&White. Prevalence of Incontinence. Women 30-60 years of age 30% have some type of urinary incontinence Increasing population of active, healthy women over 60 - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/1.jpg)
Incontinence:Evaluation and Management
Bernard D. Morris, Jr, MD, FACS
Killeen Hemingway ClinicsScott&White
![Page 2: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/2.jpg)
Prevalence of Incontinence
• Women 30-60 years of age• 30% have some type of urinary
incontinence• Increasing population of active,
healthy women over 60• Decreasing morbidity of Rx options
![Page 3: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/3.jpg)
Incontinence Underreported
• Embarrassment• Misunderstanding of causes• Low expectation of benefits from
treatments• Never asked by provider• Patient does not want to “bother”
provider
![Page 4: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/4.jpg)
Incontinence- Cost
• Financial • Physical • Psychological• Indirect costs of consequences• Loss of independence
![Page 5: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/5.jpg)
Types of Incontinence• Stress Urinary Incontinence• Urge Incontinence• Mixed Urinary Incontinence• Stress-induced Urge Incontinence• Overflow Incontinence• Cognitive/awareness issues
![Page 6: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/6.jpg)
Evaluation of Incontinence
• Focused history• Focused physical examination• Objective demonstration of SUI• Post-void residual
![Page 7: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/7.jpg)
Indications for Urologic Evaluation
• Hematuria• Large post-void residual• Abnormal urine cytology• Refractory symptoms after failed
aggressive rx• Neurologic diagnosis
![Page 8: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/8.jpg)
Urge Incontinence• Medical management• Improvement in molecular
characteristics• Improvement in delivery systems
![Page 9: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/9.jpg)
Urge Incontinence
• Physical therapy• Biofeedback• Peripheral nerve stimulators
![Page 10: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/10.jpg)
Urge Incontinece• Surgical options - rare• Interstim• Botox injections• Bladder augmentation
![Page 11: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/11.jpg)
Other diagnostic testing (prn)
• Voiding diary• Urodynamic evaluation• Cystoscopy• Imaging studies
![Page 12: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/12.jpg)
Indications for diagnostic tests
• Diagnosis unclear• Mixed incontinence• Prior pelvic floor surgery• Neurogenic diagnoses• Hematuria/pyuria• Large post-void residual• Grade 3-4 prolapse• Dysfunctional voiding
![Page 13: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/13.jpg)
Stress IncontinenceNon-surgical Rx
• Physical therapy• Biofeedback• Acupuncture• Nerve stimulatorsAppropriate patient selection and
expectations
![Page 14: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/14.jpg)
Stress IncontineceSurgical Rx
• Retropubic suspensions• Slings• Injectable agents• Artificial Urinary Sphincter
![Page 15: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/15.jpg)
Retropubic Suspensions• Gold standard for long-term results• 75-85% at 48 months• Retention 15%• Post-operative complications
involving intestines/ureters• Invasive
![Page 16: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/16.jpg)
Slings• Continuous evolution of materials
and techniques• Autologous vs synthetic• Bladder neck vs mid-urethra• Retropubic vs trans-obturator vs
needleless• Adjustable sling
![Page 17: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/17.jpg)
Slings• Retention 3-8%• Erosion/infection <5%• 85% success at 48 months• Decreased morbidity has led to
expanded population of appropriate candidates
![Page 18: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/18.jpg)
Injectable Agents• Sub-mucosal bulking agents for
intrinsic sphincteric deficiency (type 3) incontinence
• Lack of the ideal bulking agent• Minimally invasive, local anesthetic
![Page 19: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/19.jpg)
Injectable Agents• Teflon• Autologous fat• Collagen• Calcium hydroxy-apatite (Coaptite)• Inert synthetic agents (Durasphere)
![Page 20: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/20.jpg)
Artificial Urinary Sphincter
• Limited indications in women
![Page 21: Incontinence: Evaluation and Management](https://reader038.vdocuments.mx/reader038/viewer/2022110104/56815f85550346895dce8a14/html5/thumbnails/21.jpg)
Stress IncontinenceManagement
• Patient selection• Patient expectations• Patient preferences